Wall Street brokerages expect Nextgen Healthcare Inc (NASDAQ:NXGN) to announce earnings per share (EPS) of $0.23 for the current quarter, according to Zacks Investment Research. Nine analysts have made estimates for Nextgen Healthcare’s earnings, with the lowest EPS estimate coming in at $0.20 and the highest estimate coming in at $0.26. Nextgen Healthcare reported earnings per share of $0.24 during the same quarter last year, which would suggest a negative year-over-year growth rate of 4.2%. The company is scheduled to issue its next quarterly earnings results on Tuesday, October 29th.

On average, analysts expect that Nextgen Healthcare will report full year earnings of $0.85 per share for the current year, with EPS estimates ranging from $0.82 to $0.88. For the next financial year, analysts forecast that the company will post earnings of $1.01 per share, with EPS estimates ranging from $0.89 to $1.20. Zacks Investment Research’s EPS calculations are a mean average based on a survey of research firms that cover Nextgen Healthcare.

Nextgen Healthcare (NASDAQ:NXGN) last released its earnings results on Wednesday, July 24th. The company reported $0.10 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.15 by ($0.05). The firm had revenue of $131.86 million during the quarter, compared to the consensus estimate of $136.33 million. Nextgen Healthcare had a return on equity of 10.05% and a net margin of 4.37%. The business’s quarterly revenue was down 1.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.19 EPS.

NXGN has been the subject of a number of recent research reports. Zacks Investment Research downgraded Nextgen Healthcare from a “hold” rating to a “sell” rating and set a $17.00 target price for the company. in a research report on Tuesday, July 30th. ValuEngine downgraded Nextgen Healthcare from a “buy” rating to a “hold” rating in a research report on Thursday, August 15th. TheStreet downgraded Nextgen Healthcare from a “b-” rating to a “c+” rating in a research report on Wednesday, August 14th. KeyCorp upgraded Nextgen Healthcare from an “underweight” rating to a “sector weight” rating in a research report on Thursday, August 29th. They noted that the move was a valuation call. Finally, Dougherty & Co downgraded Nextgen Healthcare from a “neutral” rating to a “sell” rating in a research report on Thursday, July 25th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $18.43.

A number of hedge funds have recently made changes to their positions in NXGN. Parallel Advisors LLC purchased a new position in shares of Nextgen Healthcare during the first quarter valued at approximately $26,000. MERIAN GLOBAL INVESTORS UK Ltd purchased a new position in shares of Nextgen Healthcare during the first quarter valued at approximately $109,000. Meeder Asset Management Inc. increased its stake in shares of Nextgen Healthcare by 493.9% during the second quarter. Meeder Asset Management Inc. now owns 5,517 shares of the company’s stock valued at $110,000 after buying an additional 4,588 shares during the period. Piedmont Investment Advisors Inc. increased its stake in shares of Nextgen Healthcare by 6.0% during the first quarter. Piedmont Investment Advisors Inc. now owns 12,189 shares of the company’s stock valued at $205,000 after buying an additional 694 shares during the period. Finally, Convergence Investment Partners LLC increased its stake in shares of Nextgen Healthcare by 20.8% during the second quarter. Convergence Investment Partners LLC now owns 10,910 shares of the company’s stock valued at $217,000 after buying an additional 1,876 shares during the period. Hedge funds and other institutional investors own 70.67% of the company’s stock.

NASDAQ:NXGN traded down $0.04 during mid-day trading on Thursday, reaching $15.75. The stock had a trading volume of 269,315 shares, compared to its average volume of 284,391. The firm has a 50 day moving average price of $15.25 and a two-hundred day moving average price of $17.71. The stock has a market capitalization of $998.35 million, a P/E ratio of 25.82, a P/E/G ratio of 3.71 and a beta of 1.06. Nextgen Healthcare has a one year low of $13.60 and a one year high of $22.57. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.21 and a current ratio of 1.21.

About Nextgen Healthcare

NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.

Further Reading: Return on Investment (ROI)

Get a free copy of the Zacks research report on Nextgen Healthcare (NXGN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nextgen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.